...
首页> 外文期刊>癌と化学療法 >A case report of advanced cardiac cancer showing a complete response to TS-1 as neoadjuvant chemotherapy
【24h】

A case report of advanced cardiac cancer showing a complete response to TS-1 as neoadjuvant chemotherapy

机译:晚期心脏癌的病例报告显示对TS-1作为新辅助化疗的完整反应

获取原文
获取原文并翻译 | 示例

摘要

A 69-year-old female had complaints of vomiting, appetite loss and feeling of pharyngeal obstruction. She was diagnosed with a 3'-shaped advanced cardiac cancer with esophageal invasion. A biopsy revealed poorly differentiated adenocarcinoma. The tumor was T3 (SE) N2, Stage IIIB indicating a poor prognosis. After informed consent, TS-1 was administrated as preoperative chemotherapy. Chemotherapy with TS-1 was very effective, and the tumor noticeably decreased. Next, total gastrectomy was performed. Histopathological findings revealed that the primary tumor and lymph node had become scarred and fibrous, indicating a complete response (Grade 3). In the future, TS-1 can be expected to display efficacy in neoadjuvant chemotherapy for patients with advanced gastric cancer who have poor prognoses.
机译:一个69岁的女性对呕吐,食欲丧失和咽部障碍感到抱怨。 她被诊断出患有3英尺的先进心脏癌,食管侵袭。 活检显示出差差异差异差异化。 肿瘤是T3(SE)N2,IIIB阶段表明预后差。 知情同意后,TS-1作为术前化疗给药。 TS-1的化疗非常有效,肿瘤明显减少。 接下来,进行总胃切除术。 组织病理学发现表明,原发性肿瘤和淋巴结已经变得疤痕和纤维状,表明完全反应(3级)。 在未来,可以预期TS-1在患有较差的胃癌患者的患者中展示Neoadjuvant化疗的疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号